This Insider Has Just Sold Shares In Sight Sciences
Anyone interested in Sight Sciences, Inc. (NASDAQ:SGHT) should probably be aware that the Co-Founder, Paul Badawi, recently divested US$277k worth of shares in the company, at an average price of US$7.45 each. On the bright side, that sale was only 0.6% of their holding, so we doubt it's very meaningful, on its own.
Sight Sciences Insider Transactions Over The Last Year
Over the last year, we can see that the biggest insider purchase was by Independent Chairman Staffan Encrantz for US$452k worth of shares, at about US$3.59 per share. Even though the purchase was made at a significantly lower price than the recent price (US$7.44), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
Over the last year, we can see that insiders have bought 351.45k shares worth US$1.4m. But they sold 312.58k shares for US$1.3m. Overall, Sight Sciences insiders were net buyers during the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
View our latest analysis for Sight Sciences
Sight Sciences is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Insider Ownership Of Sight Sciences
Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Insiders own 21% of Sight Sciences shares, worth about US$82m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
What Might The Insider Transactions At Sight Sciences Tell Us?
The insider sales have outweighed the insider buying, at Sight Sciences, in the last three months. In contrast, they appear keener if you look at the last twelve months. We like that insiders own a fair amount of the company. So we're happy enough to look past some selling. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 3 warning signs for Sight Sciences and we suggest you have a look.
But note: Sight Sciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.